Literature DB >> 18561879

Good clinical practice in developing countries: applying recommendations.

François Bompart1, François Hirsch, Pierre-Henri Bertoye, Muriel Vray.   

Abstract

The recommendations for clinical research in developing countries were published in 2007 and the present article deals with issues which were not initially raised or discussed in depth. In particular, we discuss specific questions linked to trials conducted in developing countries with regard to informed consent, research project review by two ethics committees, standards of care, management of biological samples, study follow-up committees, notification of Serious Adverse Events, paediatric trials, and Contract Research Organizations.

Mesh:

Year:  2008        PMID: 18561879     DOI: 10.2515/therapie:2008022

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  2 in total

1.  Obtaining valid laboratory data in clinical trials conducted in resource diverse settings: lessons learned from a microbicide phase III clinical trial.

Authors:  Tania Crucitti; Katrien Fransen; Rashika Maharaj; Tom Tenywa; Marguerite Massinga Loembé; Kailapuri Gangatharan Murugavel; Kevin Mendonca; Said Abdellati; Greet Beelaert; Lut Van Damme
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

Review 2.  Assessing the detection, reporting and investigation of adverse events in clinical trial protocols implemented in Cameroon: a documentary review of clinical trial protocols.

Authors:  Akoh Walter Ebile; Jerome Ateudjieu; Martin Ndinakie Yakum; Marceline Ngounoue Djuidje; Pierre Watcho
Journal:  BMC Med Ethics       Date:  2015-09-29       Impact factor: 2.652

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.